Skip to main content
PHYSIOMICS PLC logo

PHYSIOMICS PLC — Investor Relations & Filings

Ticker · PYC ISIN · GB00BDR6W943 LEI · 213800A71DSZ6ABMTQ91 IL Professional, scientific and technical activities
Open in API
Filings indexed 332 across all filing types
Latest filing 2022-05-04 Board/Management Inform…
Country GB United Kingdom
Listing IL PYC

About PHYSIOMICS PLC

https://www.physiomics.co.uk/

Physiomics PLC is a data-driven consultancy that provides Model-Informed Drug Development (MIDD) services to pharmaceutical and biotechnology companies. The company specializes in accelerating and de-risking the development of new drugs by integrating expertise in Modelling & Simulation, Biostatistics, and Data Science. By applying quantitative pharmacology and pharmacokinetic/pharmacodynamic (PK/PD) modelling, Physiomics supports clients in making smarter, data-driven decisions throughout the drug development pipeline, from preclinical discovery to clinical trials. The company has a notable focus on oncology, leveraging advanced computational biology platforms to optimize treatment strategies and predict patient outcomes.

Recent filings

Filing Released Lang Actions
Physiomics expands technical team
Board/Management Information Classification · 1% confidence The document is a short announcement dated May 4, 2022, distributed via RNS (though explicitly marked as a 'Reach' non-regulatory press release distribution service). The content announces a specific personnel change: the hiring of Dr. Cristian Gradinaru as a Senior PKPD Modeller. This type of announcement—concerning changes in senior personnel—directly aligns with the definition of Board/Management Information (MANG). It is not a full financial report (10-K, IR), an earnings release (ER), or a proxy statement (DEF 14A). Given the specific nature of the announcement (hiring a senior technical team member), MANG is the most appropriate classification over the general fallback RNS.
2022-05-04 English
Issue of Options
Share Issue/Capital Change Classification · 1% confidence The document is identified by the 'RNS Number' header and contains standard regulatory boilerplate language from the London Stock Exchange's news service ('This information is provided by RNS...'). The content explicitly announces the 'Issue of Options' to non-director employees under an existing share option scheme. This action involves changes to the potential share capital/incentive structure, but it is not a formal capital raise (CAP) or a general share issue announcement (SHA). It is a specific corporate action announcement distributed via the RNS system. Since it details the issuance of options (a form of equity incentive/capital structure adjustment) and is distributed through the RNS mechanism, it fits best under the general Regulatory Filings (RNS) category, as it is a mandatory disclosure via the primary information provider, rather than a specific financial report or management change. Given the nature of the announcement (employee options) and the distribution channel (RNS), RNS is the most appropriate classification.
2022-04-29 English
Contract award
Regulatory Filings Classification · 1% confidence The document begins with 'RNS Number : 7002H' and concludes with information about RNS, the news service of the London Stock Exchange, which acts as a Primary Information Provider. The content announces a 'Contract award' for Physiomics plc, detailing a new business agreement. This type of announcement, which is a general regulatory update or news release distributed via the RNS system and does not fit into specific categories like ER, 10-K, or DIV, is best classified as a general Regulatory Filing or announcement. Given the options, 'Regulatory Filings (RNS)' is the most appropriate fallback for general, non-specific regulatory news releases distributed through this channel.
2022-04-08 English
Appointment of Independent Non-Executive Director
Board/Management Information Classification · 1% confidence The document is an official announcement disseminated via RNS (RNS Number : 3065G) on March 29, 2022. The core content announces the appointment of a new Independent Non-Executive Director, Dr Tim Corn, effective April 1, 2022. This type of announcement, detailing changes in senior management or the board of directors, directly corresponds to the definition of 'Board/Management Information' (MANG). Although it is distributed via RNS, the specific subject matter is a management change, making MANG the most precise classification over the general RNS fallback.
2022-03-29 English
Interim Results
Interim / Quarterly Report Classification · 1% confidence The document is titled 'Interim Results Statement' for the six-month period ended 31 December 2021. It contains detailed unaudited financial statements, including the Statement of Comprehensive Income, Statement of Financial Position, and Statement of Changes in Equity. As it provides comprehensive financial data for a period shorter than a full fiscal year, it is classified as an Interim/Quarterly Report (IR). H1 2022
2022-03-07 English
Notice of Interim Results & Investor Presentation
Report Publication Announcement Classification · 1% confidence The document is a short announcement (under 5,000 characters) from Physiomics PLC regarding the upcoming release of their interim results and an invitation to an investor presentation. It does not contain the actual financial results, but rather serves as a notification of when those results will be published. According to the 'Menu vs Meal' rule, this is classified as a Report Publication Announcement (RPA).
2022-03-02 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.